RU2002114044A - L-пантолактон-гидролаза и способ получения d-пантолактона - Google Patents
L-пантолактон-гидролаза и способ получения d-пантолактона Download PDFInfo
- Publication number
- RU2002114044A RU2002114044A RU2002114044/13A RU2002114044A RU2002114044A RU 2002114044 A RU2002114044 A RU 2002114044A RU 2002114044/13 A RU2002114044/13 A RU 2002114044/13A RU 2002114044 A RU2002114044 A RU 2002114044A RU 2002114044 A RU2002114044 A RU 2002114044A
- Authority
- RU
- Russia
- Prior art keywords
- acid sequence
- pantolactone
- nucleic acid
- microorganism
- hydrolase
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims 2
- 150000007523 nucleic acids Chemical group 0.000 claims 13
- 244000005700 microbiome Species 0.000 claims 12
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 10
- 238000000034 method Methods 0.000 claims 8
- 102000004157 Hydrolases Human genes 0.000 claims 7
- 108090000604 Hydrolases Proteins 0.000 claims 7
- SERHXTVXHNVDKA-BYPYZUCNSA-N (R)-pantolactone Chemical compound CC1(C)COC(=O)[C@@H]1O SERHXTVXHNVDKA-BYPYZUCNSA-N 0.000 claims 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 241000894006 Bacteria Species 0.000 claims 4
- 230000003993 interaction Effects 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- SERHXTVXHNVDKA-UHFFFAOYSA-N pantolactone Chemical compound CC1(C)COC(=O)C1O SERHXTVXHNVDKA-UHFFFAOYSA-N 0.000 claims 3
- 229940115458 pantolactone Drugs 0.000 claims 3
- SIEVQTNTRMBCHO-UHFFFAOYSA-N pantolactone Natural products CC1(C)OC(=O)CC1O SIEVQTNTRMBCHO-UHFFFAOYSA-N 0.000 claims 3
- 229920001184 polypeptide Polymers 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- OTOIIPJYVQJATP-SCSAIBSYSA-N (2s)-2,4-dihydroxy-3,3-dimethylbutanoic acid Chemical compound OCC(C)(C)[C@H](O)C(O)=O OTOIIPJYVQJATP-SCSAIBSYSA-N 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- SERHXTVXHNVDKA-SCSAIBSYSA-N (3s)-3-hydroxy-4,4-dimethyloxolan-2-one Chemical compound CC1(C)COC(=O)[C@H]1O SERHXTVXHNVDKA-SCSAIBSYSA-N 0.000 claims 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 241000589158 Agrobacterium Species 0.000 claims 1
- 241001135756 Alphaproteobacteria Species 0.000 claims 1
- 241001135755 Betaproteobacteria Species 0.000 claims 1
- 241001453380 Burkholderia Species 0.000 claims 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 1
- 241000588921 Enterobacteriaceae Species 0.000 claims 1
- 241000588722 Escherichia Species 0.000 claims 1
- 241000192128 Gammaproteobacteria Species 0.000 claims 1
- 241000947836 Pseudomonadaceae Species 0.000 claims 1
- 241000589516 Pseudomonas Species 0.000 claims 1
- 241001633102 Rhizobiaceae Species 0.000 claims 1
- 241000607142 Salmonella Species 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 229960001484 edetic acid Drugs 0.000 claims 1
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 230000002068 genetic effect Effects 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 230000000284 resting effect Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Claims (20)
1. Выделенная последовательность нуклеиновых кислот, кодирующая полипептид с активностью L-пантолактон-гидролазы, выбранная из группы, включающей а) последовательность нуклеиновых кислот с представленной в SEQ ID NO: 1 последовательностью, б) последовательности нуклеиновых кислот, которые отводятся как результат дегенерированного генетического кода от представленной в SEQ ID NO: 1 последовательности нуклеиновых кислот, в) производные представленной в SEQ ID NO: 1 последовательности нуклеиновых кислот, которые кодирует полипептиды с представленной в SEQ ID NO: 2 аминокислотной последовательностью и которые имеют по меньшей мере 50% гомологии на аминокислотном уровне, без значительного снижения ферментативной активности полипептидов,
г) функциональные эквиваленты приведенных в пунктах от (а) до (в) последовательностей.
2. Аминокислотная последовательность, кодированная последовательностью нуклеиновых кислот по п.1.
3. Аминокислотная последовательность по п.2, кодированная представленной в SEQ ID NO: 1 последовательностью.
4. Конструкт нуклеиновой кислоты, содержащий последовательность нуклеиновых кислот по п.1, причем последовательность нуклеиновых кислот связана с несколькими регуляторными сигналами.
5. Вектор, содержащий последовательность нуклеиновых кислот по п.1 или конструкт нуклеиновых кислот по п.4.
6. Микроорганизм, содержащий последовательность нуклеиновых кислот по п.1, по меньшей мере один конструкт нуклеиновых кислот по п.4 или вектор по п.5.
7. Микроорганизм по п.6, отличающийся тем, что микроорганизмом является грам-отрицательной бактерией.
8. Микроорганизм по п.6 или 7, отличающийся тем, что микроорганизмом является бактерия из группы, включающей α-протеобактерии, β-протеобактерии или γ-протеобактерии.
9. Микроорганизм по пп.6-8, отличающийся тем, что микроорганизмом является бактерия из семейства Enterobacteriaceae, Pseudomonadaceae или Rhizobiaceae.
10. Микроорганизм по пп.6-8, отличающийся тем, что микроорганизмом является бактерия вида Agrobacterium, Pseudomonas, Burkholderia, Salmonella или Escherichia.
11. L-пантолактон-гидролаза, отличающаяся следующими свойствами: a) превращением L-пантолактона в соответствующую кислоту, b) стабильностью значения рН: L-пантолактон гидролаза стабильна в диапазоне значений рН от 4 до 10, c) оптимальными значениями рН: от 7,2 до 7,6, d) оптимальными температурами 70-75°С, e) не имеет места ингибирование активности посредством этилендиамино-тетрауксусной кислоты.
12. Способ получения D-пантолактона, отличающийся тем, что он включает следующие стадии: а) взаимодействие рацемического пантолактона в присутствии L-пантолактон-гидролазы по п.11 или L-пантолактон-гидролазы с аминокислотной последовательности по п.2 или микроорганизма по п.6 с получением D-пантолактона и L-пантоиновой кислоты, б) отделение D-пантолактона.
13. Способ по п.12, отличающийся тем, что полученную на стадии (б) L-пантоиновую кислоту рацемизируют и возвращают на стадию (а).
14. Способ по п.12 или 13, отличающийся тем, что взаимодействие рацемического пантолактона проводят в присутствии иммобилизированной L-пантолактон-гидролазы по п.11 или иммобилизированной L-пантолактон-гидролазы с аминокислотной последовательностью по п.2.
15. Способ по п.12 или 13, отличающийся тем, что взаимодействие рацемического пантолактона проводят в присутствии промытого, покоящегося или вскрытого микроорганизма по п.6.
16. Способ по п.12 или 15, отличающийся тем, что микроорганизм иммобилизирован.
17. Способ по пп.12-16, отличающийся тем, что его проводят в водной реакционной смеси при значении рН между 4 и 12.
18. Способ по пп.12-17, отличающийся тем, что его проводят при температуре 0-95°С.
19. Способ по п.12 или 13, отличающийся тем, что D-пантолактон отделяют экстракцией.
20. Способ по пп.12-18, отличающийся тем, что D-пантолактон имеет оптическую чистоту по меньшей мере 90%.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19952501A DE19952501A1 (de) | 1999-10-29 | 1999-10-29 | L-Pantolacton-Hydrolase und ein Verfahren zur Herstellung von D-Pantolacton |
| DE19952501.3 | 1999-10-29 | ||
| DE10029194A DE10029194A1 (de) | 2000-06-19 | 2000-06-19 | L-Pantolacton-Hydrolase und ein Verfahren zur Herstellung von D-Pantolacton |
| DE10029194.5 | 2000-06-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2002114044A true RU2002114044A (ru) | 2004-03-27 |
Family
ID=26006072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2002114044/13A RU2002114044A (ru) | 1999-10-29 | 2000-10-20 | L-пантолактон-гидролаза и способ получения d-пантолактона |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6998258B1 (ru) |
| EP (1) | EP1224296A1 (ru) |
| JP (1) | JP2003530080A (ru) |
| KR (1) | KR20020043254A (ru) |
| CN (1) | CN1384880A (ru) |
| AU (1) | AU782517B2 (ru) |
| BR (1) | BR0015114A (ru) |
| CA (1) | CA2389064A1 (ru) |
| CZ (1) | CZ20021449A3 (ru) |
| EE (1) | EE200200225A (ru) |
| HU (1) | HUP0203704A3 (ru) |
| IL (1) | IL148973A0 (ru) |
| MX (1) | MXPA02003417A (ru) |
| NO (1) | NO20021931L (ru) |
| PL (1) | PL355487A1 (ru) |
| RU (1) | RU2002114044A (ru) |
| WO (1) | WO2001032890A1 (ru) |
Families Citing this family (86)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030194798A1 (en) * | 2001-05-24 | 2003-10-16 | Surber Mark W. | Minicell compositions and methods |
| AU2003288189B8 (en) | 2002-12-02 | 2009-06-25 | Basf Aktiengesellschaft | L-rhamnose-inducible expression systems |
| CN1768141B (zh) * | 2003-03-28 | 2012-10-10 | 帝斯曼知识产权资产管理有限公司 | 泛酸内酯水解酶 |
| CN101448950B (zh) * | 2006-05-16 | 2014-02-12 | 帝斯曼知识产权资产管理有限公司 | 用于生产泛醇的工艺 |
| PT2061897T (pt) | 2006-07-27 | 2020-05-08 | Wyeth Llc | Processo de fermentação em lote alimentado de densidade celular elevada para produção de proteína recombinante |
| US9682254B2 (en) | 2008-05-22 | 2017-06-20 | Vladimir Balakin | Cancer surface searing apparatus and method of use thereof |
| US9855444B2 (en) | 2008-05-22 | 2018-01-02 | Scott Penfold | X-ray detector for proton transit detection apparatus and method of use thereof |
| US8198607B2 (en) * | 2008-05-22 | 2012-06-12 | Vladimir Balakin | Tandem accelerator method and apparatus used in conjunction with a charged particle cancer therapy system |
| US9155911B1 (en) | 2008-05-22 | 2015-10-13 | Vladimir Balakin | Ion source method and apparatus used in conjunction with a charged particle cancer therapy system |
| US8519365B2 (en) * | 2008-05-22 | 2013-08-27 | Vladimir Balakin | Charged particle cancer therapy imaging method and apparatus |
| US8969834B2 (en) | 2008-05-22 | 2015-03-03 | Vladimir Balakin | Charged particle therapy patient constraint apparatus and method of use thereof |
| US9056199B2 (en) | 2008-05-22 | 2015-06-16 | Vladimir Balakin | Charged particle treatment, rapid patient positioning apparatus and method of use thereof |
| US9737734B2 (en) | 2008-05-22 | 2017-08-22 | Susan L. Michaud | Charged particle translation slide control apparatus and method of use thereof |
| US10548551B2 (en) | 2008-05-22 | 2020-02-04 | W. Davis Lee | Depth resolved scintillation detector array imaging apparatus and method of use thereof |
| US9044600B2 (en) * | 2008-05-22 | 2015-06-02 | Vladimir Balakin | Proton tomography apparatus and method of operation therefor |
| US8399866B2 (en) | 2008-05-22 | 2013-03-19 | Vladimir Balakin | Charged particle extraction apparatus and method of use thereof |
| US9737733B2 (en) | 2008-05-22 | 2017-08-22 | W. Davis Lee | Charged particle state determination apparatus and method of use thereof |
| US8642978B2 (en) | 2008-05-22 | 2014-02-04 | Vladimir Balakin | Charged particle cancer therapy dose distribution method and apparatus |
| US10684380B2 (en) | 2008-05-22 | 2020-06-16 | W. Davis Lee | Multiple scintillation detector array imaging apparatus and method of use thereof |
| US9095040B2 (en) | 2008-05-22 | 2015-07-28 | Vladimir Balakin | Charged particle beam acceleration and extraction method and apparatus used in conjunction with a charged particle cancer therapy system |
| US8378311B2 (en) | 2008-05-22 | 2013-02-19 | Vladimir Balakin | Synchrotron power cycling apparatus and method of use thereof |
| US20090314960A1 (en) * | 2008-05-22 | 2009-12-24 | Vladimir Balakin | Patient positioning method and apparatus used in conjunction with a charged particle cancer therapy system |
| US8178859B2 (en) | 2008-05-22 | 2012-05-15 | Vladimir Balakin | Proton beam positioning verification method and apparatus used in conjunction with a charged particle cancer therapy system |
| US9782140B2 (en) | 2008-05-22 | 2017-10-10 | Susan L. Michaud | Hybrid charged particle / X-ray-imaging / treatment apparatus and method of use thereof |
| US8436327B2 (en) * | 2008-05-22 | 2013-05-07 | Vladimir Balakin | Multi-field charged particle cancer therapy method and apparatus |
| US9177751B2 (en) | 2008-05-22 | 2015-11-03 | Vladimir Balakin | Carbon ion beam injector apparatus and method of use thereof |
| US9498649B2 (en) | 2008-05-22 | 2016-11-22 | Vladimir Balakin | Charged particle cancer therapy patient constraint apparatus and method of use thereof |
| US8975600B2 (en) | 2008-05-22 | 2015-03-10 | Vladimir Balakin | Treatment delivery control system and method of operation thereof |
| US9616252B2 (en) | 2008-05-22 | 2017-04-11 | Vladimir Balakin | Multi-field cancer therapy apparatus and method of use thereof |
| US8309941B2 (en) * | 2008-05-22 | 2012-11-13 | Vladimir Balakin | Charged particle cancer therapy and patient breath monitoring method and apparatus |
| US8624528B2 (en) * | 2008-05-22 | 2014-01-07 | Vladimir Balakin | Method and apparatus coordinating synchrotron acceleration periods with patient respiration periods |
| US10070831B2 (en) | 2008-05-22 | 2018-09-11 | James P. Bennett | Integrated cancer therapy—imaging apparatus and method of use thereof |
| US10143854B2 (en) | 2008-05-22 | 2018-12-04 | Susan L. Michaud | Dual rotation charged particle imaging / treatment apparatus and method of use thereof |
| US9168392B1 (en) | 2008-05-22 | 2015-10-27 | Vladimir Balakin | Charged particle cancer therapy system X-ray apparatus and method of use thereof |
| US9744380B2 (en) | 2008-05-22 | 2017-08-29 | Susan L. Michaud | Patient specific beam control assembly of a cancer therapy apparatus and method of use thereof |
| US8288742B2 (en) * | 2008-05-22 | 2012-10-16 | Vladimir Balakin | Charged particle cancer therapy patient positioning method and apparatus |
| US9974978B2 (en) | 2008-05-22 | 2018-05-22 | W. Davis Lee | Scintillation array apparatus and method of use thereof |
| US8598543B2 (en) * | 2008-05-22 | 2013-12-03 | Vladimir Balakin | Multi-axis/multi-field charged particle cancer therapy method and apparatus |
| US8129699B2 (en) | 2008-05-22 | 2012-03-06 | Vladimir Balakin | Multi-field charged particle cancer therapy method and apparatus coordinated with patient respiration |
| US8710462B2 (en) * | 2008-05-22 | 2014-04-29 | Vladimir Balakin | Charged particle cancer therapy beam path control method and apparatus |
| US8373146B2 (en) * | 2008-05-22 | 2013-02-12 | Vladimir Balakin | RF accelerator method and apparatus used in conjunction with a charged particle cancer therapy system |
| US9910166B2 (en) | 2008-05-22 | 2018-03-06 | Stephen L. Spotts | Redundant charged particle state determination apparatus and method of use thereof |
| US8188688B2 (en) | 2008-05-22 | 2012-05-29 | Vladimir Balakin | Magnetic field control method and apparatus used in conjunction with a charged particle cancer therapy system |
| US8907309B2 (en) | 2009-04-17 | 2014-12-09 | Stephen L. Spotts | Treatment delivery control system and method of operation thereof |
| US9937362B2 (en) | 2008-05-22 | 2018-04-10 | W. Davis Lee | Dynamic energy control of a charged particle imaging/treatment apparatus and method of use thereof |
| US8718231B2 (en) | 2008-05-22 | 2014-05-06 | Vladimir Balakin | X-ray tomography method and apparatus used in conjunction with a charged particle cancer therapy system |
| US8637833B2 (en) | 2008-05-22 | 2014-01-28 | Vladimir Balakin | Synchrotron power supply apparatus and method of use thereof |
| US8373145B2 (en) * | 2008-05-22 | 2013-02-12 | Vladimir Balakin | Charged particle cancer therapy system magnet control method and apparatus |
| US8374314B2 (en) | 2008-05-22 | 2013-02-12 | Vladimir Balakin | Synchronized X-ray / breathing method and apparatus used in conjunction with a charged particle cancer therapy system |
| US8368038B2 (en) | 2008-05-22 | 2013-02-05 | Vladimir Balakin | Method and apparatus for intensity control of a charged particle beam extracted from a synchrotron |
| US8089054B2 (en) | 2008-05-22 | 2012-01-03 | Vladimir Balakin | Charged particle beam acceleration and extraction method and apparatus used in conjunction with a charged particle cancer therapy system |
| US8373143B2 (en) * | 2008-05-22 | 2013-02-12 | Vladimir Balakin | Patient immobilization and repositioning method and apparatus used in conjunction with charged particle cancer therapy |
| US7939809B2 (en) * | 2008-05-22 | 2011-05-10 | Vladimir Balakin | Charged particle beam extraction method and apparatus used in conjunction with a charged particle cancer therapy system |
| US9981147B2 (en) | 2008-05-22 | 2018-05-29 | W. Davis Lee | Ion beam extraction apparatus and method of use thereof |
| US10092776B2 (en) | 2008-05-22 | 2018-10-09 | Susan L. Michaud | Integrated translation/rotation charged particle imaging/treatment apparatus and method of use thereof |
| US9579525B2 (en) | 2008-05-22 | 2017-02-28 | Vladimir Balakin | Multi-axis charged particle cancer therapy method and apparatus |
| US8378321B2 (en) * | 2008-05-22 | 2013-02-19 | Vladimir Balakin | Charged particle cancer therapy and patient positioning method and apparatus |
| US10029122B2 (en) | 2008-05-22 | 2018-07-24 | Susan L. Michaud | Charged particle—patient motion control system apparatus and method of use thereof |
| US8569717B2 (en) * | 2008-05-22 | 2013-10-29 | Vladimir Balakin | Intensity modulated three-dimensional radiation scanning method and apparatus |
| US9737272B2 (en) | 2008-05-22 | 2017-08-22 | W. Davis Lee | Charged particle cancer therapy beam state determination apparatus and method of use thereof |
| US8627822B2 (en) * | 2008-07-14 | 2014-01-14 | Vladimir Balakin | Semi-vertical positioning method and apparatus used in conjunction with a charged particle cancer therapy system |
| US8229072B2 (en) * | 2008-07-14 | 2012-07-24 | Vladimir Balakin | Elongated lifetime X-ray method and apparatus used in conjunction with a charged particle cancer therapy system |
| US8625739B2 (en) | 2008-07-14 | 2014-01-07 | Vladimir Balakin | Charged particle cancer therapy x-ray method and apparatus |
| MX2011012757A (es) | 2009-06-05 | 2011-12-16 | Basf Se | Produccion biocatalitica de ambroxan. |
| US10188877B2 (en) | 2010-04-16 | 2019-01-29 | W. Davis Lee | Fiducial marker/cancer imaging and treatment apparatus and method of use thereof |
| US10376717B2 (en) | 2010-04-16 | 2019-08-13 | James P. Bennett | Intervening object compensating automated radiation treatment plan development apparatus and method of use thereof |
| US10625097B2 (en) | 2010-04-16 | 2020-04-21 | Jillian Reno | Semi-automated cancer therapy treatment apparatus and method of use thereof |
| US10518109B2 (en) | 2010-04-16 | 2019-12-31 | Jillian Reno | Transformable charged particle beam path cancer therapy apparatus and method of use thereof |
| US10349906B2 (en) | 2010-04-16 | 2019-07-16 | James P. Bennett | Multiplexed proton tomography imaging apparatus and method of use thereof |
| US10555710B2 (en) | 2010-04-16 | 2020-02-11 | James P. Bennett | Simultaneous multi-axes imaging apparatus and method of use thereof |
| US11648420B2 (en) | 2010-04-16 | 2023-05-16 | Vladimir Balakin | Imaging assisted integrated tomography—cancer treatment apparatus and method of use thereof |
| US10751551B2 (en) | 2010-04-16 | 2020-08-25 | James P. Bennett | Integrated imaging-cancer treatment apparatus and method of use thereof |
| US9737731B2 (en) | 2010-04-16 | 2017-08-22 | Vladimir Balakin | Synchrotron energy control apparatus and method of use thereof |
| US10086214B2 (en) | 2010-04-16 | 2018-10-02 | Vladimir Balakin | Integrated tomography—cancer treatment apparatus and method of use thereof |
| US10556126B2 (en) | 2010-04-16 | 2020-02-11 | Mark R. Amato | Automated radiation treatment plan development apparatus and method of use thereof |
| US10638988B2 (en) | 2010-04-16 | 2020-05-05 | Scott Penfold | Simultaneous/single patient position X-ray and proton imaging apparatus and method of use thereof |
| US10589128B2 (en) | 2010-04-16 | 2020-03-17 | Susan L. Michaud | Treatment beam path verification in a cancer therapy apparatus and method of use thereof |
| US10179250B2 (en) | 2010-04-16 | 2019-01-15 | Nick Ruebel | Auto-updated and implemented radiation treatment plan apparatus and method of use thereof |
| US8963112B1 (en) | 2011-05-25 | 2015-02-24 | Vladimir Balakin | Charged particle cancer therapy patient positioning method and apparatus |
| US8933651B2 (en) | 2012-11-16 | 2015-01-13 | Vladimir Balakin | Charged particle accelerator magnet apparatus and method of use thereof |
| KR20180006970A (ko) | 2015-06-19 | 2018-01-19 | 바스프 에스이 | 판토락톤의 제조 |
| US9907981B2 (en) | 2016-03-07 | 2018-03-06 | Susan L. Michaud | Charged particle translation slide control apparatus and method of use thereof |
| US10037863B2 (en) | 2016-05-27 | 2018-07-31 | Mark R. Amato | Continuous ion beam kinetic energy dissipater apparatus and method of use thereof |
| EP3867391A1 (en) | 2018-10-18 | 2021-08-25 | Basf Se | Method for the production of acrylic acid or salts thereof |
| EP3748009A1 (en) * | 2019-06-07 | 2020-12-09 | DSM IP Assets B.V. | Synthesis of (r)-pantolactone acetate |
| CN110452861B (zh) * | 2019-07-10 | 2021-02-09 | 杭州师范大学 | 一种基因重组工程菌及其在催化合成d-泛酰内酯中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5572182A (en) * | 1978-11-28 | 1980-05-30 | Sagami Chem Res Center | Optical resolution of pantolactone |
| JPH0667320B2 (ja) * | 1986-06-13 | 1994-08-31 | 三菱化成株式会社 | D−パントラクトンの製造法 |
| JPH0655156B2 (ja) * | 1986-06-13 | 1994-07-27 | 三菱化成株式会社 | Dl−パントラクトンの光学分割法 |
| JP2844354B2 (ja) | 1989-08-03 | 1999-01-06 | 富士薬品工業株式会社 | D―パントラクトンの製造法 |
| DE4005150A1 (de) | 1990-02-17 | 1991-08-22 | Hoechst Ag | Verfahren zur enzymatischen racematspaltung von pantolacton |
| JP3011449B2 (ja) * | 1990-10-05 | 2000-02-21 | 富士薬品工業株式会社 | D―パントラクトン加水分解酵素およびその製造法 |
| EP0507278A3 (en) | 1991-04-02 | 1993-12-15 | Hoechst Ag | Immobilised biocatalyser, its preparation and use for ester synthesis in a column reactor |
| DE4126580A1 (de) | 1991-08-12 | 1993-02-18 | Degussa | D-2,4-dihydroxy-3,3-dimethylbutansaeurenitril, seine herstellung und verwendung |
| EP0626467B1 (en) | 1992-10-15 | 1997-05-21 | Kawasaki Steel Corporation | Method of continuously carburizing steel strip |
| DE69634815T2 (de) * | 1995-09-13 | 2006-03-23 | Daiichi Fine Chemical Co., Ltd., Takaoka | D-pantolactonhydrolase und dafür kodierendes gen |
| US6395529B1 (en) * | 1998-11-10 | 2002-05-28 | Novozymes Biotech, Inc. | Polypeptides having lactonohydrolase activity and nucleic acids encoding same |
| EP1129200A2 (en) * | 1998-11-10 | 2001-09-05 | Novozymes Biotech, Inc. | Polypeptides having lactonohydrolase activity and nucleic acids encoding same |
-
2000
- 2000-10-20 MX MXPA02003417A patent/MXPA02003417A/es unknown
- 2000-10-20 US US10/111,451 patent/US6998258B1/en not_active Expired - Fee Related
- 2000-10-20 BR BR0015114-9A patent/BR0015114A/pt not_active IP Right Cessation
- 2000-10-20 WO PCT/EP2000/010320 patent/WO2001032890A1/de not_active Ceased
- 2000-10-20 EE EEP200200225A patent/EE200200225A/xx unknown
- 2000-10-20 CZ CZ20021449A patent/CZ20021449A3/cs unknown
- 2000-10-20 JP JP2001535572A patent/JP2003530080A/ja not_active Withdrawn
- 2000-10-20 HU HU0203704A patent/HUP0203704A3/hu unknown
- 2000-10-20 IL IL14897300A patent/IL148973A0/xx unknown
- 2000-10-20 CA CA002389064A patent/CA2389064A1/en not_active Abandoned
- 2000-10-20 AU AU11416/01A patent/AU782517B2/en not_active Ceased
- 2000-10-20 RU RU2002114044/13A patent/RU2002114044A/ru not_active Application Discontinuation
- 2000-10-20 PL PL00355487A patent/PL355487A1/xx not_active Application Discontinuation
- 2000-10-20 CN CN00814937A patent/CN1384880A/zh active Pending
- 2000-10-20 KR KR1020027005466A patent/KR20020043254A/ko not_active Withdrawn
- 2000-10-20 EP EP00972817A patent/EP1224296A1/de not_active Withdrawn
-
2002
- 2002-04-24 NO NO20021931A patent/NO20021931L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20021931D0 (no) | 2002-04-24 |
| KR20020043254A (ko) | 2002-06-08 |
| IL148973A0 (en) | 2002-11-10 |
| AU1141601A (en) | 2001-05-14 |
| PL355487A1 (en) | 2004-05-04 |
| JP2003530080A (ja) | 2003-10-14 |
| AU782517B2 (en) | 2005-08-04 |
| CZ20021449A3 (cs) | 2002-10-16 |
| MXPA02003417A (es) | 2002-08-20 |
| BR0015114A (pt) | 2002-07-16 |
| WO2001032890A1 (de) | 2001-05-10 |
| NO20021931L (no) | 2002-04-24 |
| CN1384880A (zh) | 2002-12-11 |
| CA2389064A1 (en) | 2001-05-10 |
| EE200200225A (et) | 2003-06-16 |
| HUP0203704A3 (en) | 2006-03-28 |
| US6998258B1 (en) | 2006-02-14 |
| EP1224296A1 (de) | 2002-07-24 |
| HUP0203704A2 (hu) | 2003-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2002114044A (ru) | L-пантолактон-гидролаза и способ получения d-пантолактона | |
| CA2347521A1 (en) | Method for producing chiral carboxylic acids from nitriles with the assistance of a nitrilase or microorganisms which contain a gene for the nitrilase | |
| US10774356B2 (en) | Transaminases | |
| CN111433357A (zh) | 醇脱氢酶突变体及其在双芳基手性醇合成中的应用 | |
| JP6796927B2 (ja) | 酵素を用いた4−アミノ桂皮酸の製造方法 | |
| RU2002126270A (ru) | Нитрилаза из rhodococcus rhodochrous ncimb 11216 | |
| KR960014149A (ko) | 말토오스를 트레할로오스로 변환하는 재조합형 열안정성 효소 | |
| CN112852789B (zh) | 腈水解酶突变体及其应用 | |
| RU2381273C2 (ru) | Способ получения гетерогенного биокатализатора, биокатализатор на основе гидролазы эфиров альфа-аминокислот и способ синтеза аминобета-лактамного антибиотика под действием этого биокатализатора | |
| RU2004133974A (ru) | Полипептид, обладающий расщепляющей активностью по отношению к полисахариду, содержащему сульфатированную фукозу, способ его получения, кодирующие его последовательность днк и экспрессирующий вектор, способ получения трансформированной клетки e. coli | |
| CA2384122A1 (en) | Cyclic depsipeptide synthetase and gene thereof, and mass production system for cyclic depsipeptide | |
| KR960001125A (ko) | 말토오스를 트레할로오스로 변환하는 재조합형 효소 | |
| CN117384981A (zh) | 南极假丝酵母脂肪酶b的分子进化及催化高效合成内酯类化合物 | |
| AU2009303012A1 (en) | Method for preparing epsilon-caprolactam from N-acyl-6-aminocaproic acid | |
| CN116042556B (zh) | 4-氧代癸酸还原酶突变体及在制备光学纯(R)-γ内酯中的应用 | |
| RU2004105179A (ru) | 6-фосфоглюконолактоназа из escherichia coli, фрагмент днк, бактерия, принадлежащая к роду escherichia, -продуцент l-аминокислоты, и способ получения l-аминокислоты | |
| JPH11113594A (ja) | 光学活性な1−(4−t−ブチルフェニル)−5−オキソ−3−ピロリジンカルボン酸および/またはその鏡像対掌体エステルの製造方法 | |
| CN116334018A (zh) | 耐热还原胺化酶及其制法和应用 | |
| KR101715882B1 (ko) | 신규 ε-카프로락탐 전환 효소 및 이를 이용한 ε-카프로락탐 생산 방법 | |
| CA2407059A1 (en) | Novel (r)-2-hydroxy-3-phenylpropionic acid (d-phenyllactic acid) dehydrogenase and gene encoding the same | |
| US20200095563A1 (en) | Method for the extraction of recombinant proteins | |
| KR101223664B1 (ko) | 나이트릴레이즈 rmn1을 이용한 카르복실산의 제조방법 | |
| SU1731066A3 (ru) | Способ получени креатинамидиногидролазы | |
| KR101223666B1 (ko) | 나이트릴레이즈 orn을 이용한 카르복실산의 제조방법 | |
| JP4601049B2 (ja) | バチルス・サチルス由来のエポキシドハイドロラーゼを発現する微生物およびそれを用いたエポキシドハイドロラーゼの製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20051108 |